These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 19222595

  • 1. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 3. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M.
    Neurology; 2008 Nov 11; 71(20):1586-93. PubMed ID: 19001248
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 11; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 11; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 6. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Feb 11; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 7. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 11; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 11; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 11; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 10. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA, Protocol 125 study group.
    Headache; 2004 Jun 11; 44(6):581-6. PubMed ID: 15186302
    [Abstract] [Full Text] [Related]

  • 11. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 11; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.
    Headache; 2009 Jun 11; 49(6):826-37. PubMed ID: 19545249
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG, Tonabersat TON-01-05 Study Group.
    Cephalalgia; 2009 Jul 11; 29(7):742-50. PubMed ID: 19222510
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 11; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 15. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D, Sullivan T, SP755 Study Group.
    Epilepsia; 2009 Mar 11; 50(3):443-53. PubMed ID: 19183227
    [Abstract] [Full Text] [Related]

  • 16. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb 11; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 17. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 11; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group.
    Clin J Pain; 2009 Jun 11; 25(5):376-85. PubMed ID: 19454870
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.
    Trenité DG, French JA, Hirsch E, Macher JP, Meyer BU, Grosse PA, Abou-Khalil BW, Rosenfeld WE, van Gerven J, Novak GP, Parmeggiani L, Schmidt B, Gibson D, Guerrini R.
    Epilepsy Res; 2007 May 11; 74(2-3):193-200. PubMed ID: 17448639
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T.
    Clin Ther; 2009 Jun 11; 31(6):1177-91. PubMed ID: 19695386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.